Cordis Corp.
Miami Lakes, FL 33014
Share:
New Balloon Catheter Available Worldwide for Carotid and Renal Angioplasty Procedures
AVIATOR(TM) Plus Balloon Dilatation Catheter Rapid Exchange Facilitates Procedural Speed and Efficiency BALTIMORE, June 7 // -- Today at the 61st Annual Meeting of the Society for Vascular Surgery, Cordis Endovascular, division of Cordis Corporation, announced the worldwide launch of the Cordis AVIATOR(TM) Plus Balloon Dilatation Catheter for use in angioplasty procedures for patients with...
Read More »Cordis Corporation Introduces DURA STAR(TM) Rx PTCA Dilatation Catheter
BRUSSELS, April 10--- Launch in Line With Cordis' Commitment to Offer Full Range of Products for Catheterization Labs Cordis Corporation today announced the launch of the DURA STAR(TM) Rx Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilatation Catheter. The new dilatation balloon from Cordis is now available in Europe and will be introduced in other regions, including North America,...
Read More »First Hospital Nationwide Now Offers Less-Invasive Procedure for Select Patients with Obstructed Neck Arteries
Ochsner Health System in New Orleans Conducts First Carotid Procedure with Newly-Approved Stent System NEW ORLEANS, Oct. 9 -- The Ochsner Health System in New Orleans, Louisiana, conducted the first patient procedure involving the new, FDA-approved PRECISEÃ-® Nitinol Stent and ANGIOGUARDÃ-® Emboli Capture Guidewire carotid system. The new devices, marketed by Cordis Endovascular, a...
Read More »Drug-Eluting Stent promotes smooth procedures.
CYPHER SELECT(TM) Plus Stent carries CE mark and is designed to help interventional cardiologists reach and treat coronary artery blockages. In addition to flexible stent design and short tip, delivery system features lubricious CYPH2ONIC(TM) Hydrophilic Coating Technology to facilitate delivery of stent even when lesion is located in tortuous blood vessel.
Read More »Cordis STEER-IT(TM) Deflecting Tip Guidewire Now Available in the United States, Europe and Canada
Innovative Bidirectional Deflecting Tip Enables Physicians to Treat Difficult-to-Reach Blockages in Coronary, Peripheral Arteries MIAMI, Aug. 28 // -- Cordis Corporation announced today its STEER-IT(TM) Deflecting Tip Guidewire is now available for commercial use in the United States, Canada and Europe. The innovative product will be available in other parts of the world soon. The STEER-IT(TM)...
Read More »New Balloon Catheter Available Worldwide for Carotid and Renal Angioplasty Procedures
AVIATOR(TM) Plus Balloon Dilatation Catheter Rapid Exchange Facilitates Procedural Speed and Efficiency BALTIMORE, June 7 // -- Today at the 61st Annual Meeting of the Society for Vascular Surgery, Cordis Endovascular, division of Cordis Corporation, announced the worldwide launch of the Cordis AVIATOR(TM) Plus Balloon Dilatation Catheter for use in angioplasty procedures for patients with...
Read More »Cordis Corporation Signs Definitive Agreement With Medinol for Global Distribution of Bare Metal Stents
MIAMI LAKES, Florida and TEL AVIV, Israel, May 23/ -- Cordis Corporation today announced that it has signed a definitive agreement whereby it will become the exclusive global distributor of a family of bare metal stents for coronary applications developed by Medinol. Cordis will have access to Medinol's latest generation stainless steel and cobalt chromium bare metal stents. Medinol's advanced...
Read More »Cordis Corporation Introduces DURA STAR(TM) Rx PTCA Dilatation Catheter
BRUSSELS, April 10--- Launch in Line With Cordis' Commitment to Offer Full Range of Products for Catheterization Labs Cordis Corporation today announced the launch of the DURA STAR(TM) Rx Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilatation Catheter. The new dilatation balloon from Cordis is now available in Europe and will be introduced in other regions, including North America,...
Read More »New Clinical Data for Cypher-® Sirolimus-Eluting Coronary Stent & Innovative Cordis Technologies to Be Showcased at World Congress of Cardiology 2006
MIAMI, Aug. 29-- Cordis Corporation and some of its European affiliates will report on new clinical study data, introduce new products for the treatment of cardiovascular disease, host a drug-eluting stent educational symposium and promote the global CordisÃ-® Cardiac & Vascular Institute(SM) at the upcoming World Congress of Cardiology (WCC) 2006, taking place in Barcelona, Spain, from Sept....
Read More »First Hospital Nationwide Now Offers Less-Invasive Procedure for Select Patients with Obstructed Neck Arteries
Ochsner Health System in New Orleans Conducts First Carotid Procedure with Newly-Approved Stent System NEW ORLEANS, Oct. 9 -- The Ochsner Health System in New Orleans, Louisiana, conducted the first patient procedure involving the new, FDA-approved PRECISEÃ-® Nitinol Stent and ANGIOGUARDÃ-® Emboli Capture Guidewire carotid system. The new devices, marketed by Cordis Endovascular, a...
Read More »Drug-Eluting Stent promotes smooth procedures.
CYPHER SELECT(TM) Plus Stent carries CE mark and is designed to help interventional cardiologists reach and treat coronary artery blockages. In addition to flexible stent design and short tip, delivery system features lubricious CYPH2ONIC(TM) Hydrophilic Coating Technology to facilitate delivery of stent even when lesion is located in tortuous blood vessel.
Read More »Cordis STEER-IT(TM) Deflecting Tip Guidewire Now Available in the United States, Europe and Canada
Innovative Bidirectional Deflecting Tip Enables Physicians to Treat Difficult-to-Reach Blockages in Coronary, Peripheral Arteries MIAMI, Aug. 28 // -- Cordis Corporation announced today its STEER-IT(TM) Deflecting Tip Guidewire is now available for commercial use in the United States, Canada and Europe. The innovative product will be available in other parts of the world soon. The STEER-IT(TM)...
Read More »Cordis Corporation to Establish New Innovative Research Center in Silicon Valley
Chief Technology Officer to Drive Strategy MIAMI, May 25 /PRNewswire-FirstCall/ -- Cordis Corporation today announced plans to extend its current research and development operations by establishing a unique innovation center in the Bay Area of northern California. With an entrepreneurial culture and environment, the center will allow engineers and other researchers to strive for innovative new...
Read More »Cordis Corporation to Develop Global Cardiac and Vascular Institute
Initiative to Focus on Advanced Training for Health Care Providers and Global Innovation MIAMI LAKES, Fla., and WARREN, N.J., April 4 / -- Cordis Corporation announced today plans to develop a world-class global cardiac and vascular institute that will provide physicians and other health care providers with educational and clinical resources designed to help advance the understanding and...
Read More »